Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1774 | Kukaa Salama: mHealth intervention Wiki | 1.00 |
drug1279 | Face Mask + Soap Wiki | 1.00 |
drug686 | Camostat Mesilate Wiki | 0.32 |
Name (Synonyms) | Correlation | |
---|---|---|
D003141 | Communicable Diseases NIH | 0.07 |
D007239 | Infection NIH | 0.05 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
This will be a randomized, open-label study to determine if camostat or camostat+ bicalutamide decreases the proportion of people with COVID-19 who require hospitalization, compared to historical controls. Patients with symptomatic COVID-19, diagnosed as outpatients, will be randomized 1:1:1, stratified by gender, to treatment with standard of care alone (Arm 1) or with camostat (Arm 2) or with camostat and bicalutamide (Arm 3).
Description: Number of outpatient participants diagnosed with COVID-19 who require hospitalization by day 28
Measure: Number of participants requiring hospitalization Time: up to 28 daysDescription: Number of adverse events, as defined by NCI CTCAE version 5.0, that are related to the study drug (or therapy)
Measure: Number of drug-related adverse events Time: up to 60 daysDescription: Number of serious adverse events, as defined by NCI CTCAE version 5.0, that are related to the study drug (or therapy)
Measure: Number of drug-related serious adverse events Time: up to 60 daysDescription: Number of participants deceased.
Measure: All-cause mortality Time: up to 60 daysDescription: Number of calendar days in the hospital
Measure: Duration of hospitalization Time: up to 60 daysDescription: Number of calendar days in IMC unit
Measure: Duration of IMC stay Time: up to 60 daysDescription: Number of calendar days in ICU
Measure: Duration of ICU stay Time: up to 60 daysDescription: Number of calendar days requiring mechanical ventilation
Measure: Duration on mechanical ventilation Time: up to 60 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports